Shanghai Haohai Biological Technology Co., Ltd. (SHA:688366)

Market Cap	6.66B -36.9%
Revenue (ttm)	2.40B -9.5%
Net Income	234.26M -43.3%
EPS	1.01 -42.9%
Shares Out	n/a
PE Ratio	28.44
Forward PE	n/a
Dividend	1.00 (2.92%)
Ex-Dividend Date	Oct 16, 2025

Volume	313,602
Open	32.34
Previous Close	32.21
Day's Range	32.34 - 32.99
52-Week Range	32.03 - 58.97
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 24, 2026

About SHA:688366

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,110
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688366

Financial Performance

In 2025, SHA:688366's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.